Showing results (1041-1050 of 1,116) with videos related to
Sort By:
Pageof 112
Cell Host & Microbe|April 26, 2024
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody inductionKevin Wiehe, Kevin O Saunders, Victoria Stalls, et al.Journal of Crohn'S & Colitis|September 28, 2023
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis SubtypesTenghao Zheng, Giulia Roda, Yamile Zabana, et al.The Journal of Rheumatology|September 3, 2018
Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus ErythematosusStephanie O Keeling, Zainab Alabdurubalnabi, Antonio Avina-Zubieta, et al.Proceedings of the National Academy of Sciences of the United States of America|July 16, 2025
Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivoVladimir V Shuvaev, Ying K Tam, Benjamin W Lee, et al.The Lancet. Gastroenterology & Hepatology|November 14, 2021
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch ConsortiumBo Shen, Gursimran S Kochhar, David T Rubin, et al.The Lancet. Gastroenterology & Hepatology|August 20, 2021
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch ConsortiumBo Shen, Gursimran S Kochhar, Revital Kariv, et al.Science Translational Medicine|October 15, 2025
Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in miceGrace G Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.Annals of the New York Academy of Sciences|April 6, 2023
Progress in vaccine development for infectious diseases-a Keystone Symposia reportJennifer Cable, Barney S Graham, Richard A Koup, et al.Advances in Therapy|June 30, 2026
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyGiuseppe Privitera, Flavia Palumbo, Fabio Salvatore Macaluso, et al.Pageof 112